All articles
9 min read

ICH Stability Zones: Which Long-Term Condition Your Market Needs

ICH stability zones set the long-term condition at 25°C/60% RH for zones I and II, 30°C/65% RH for IVa and 30°C/75% RH for IVb; use your market's listed condition or the harshest.

By Sunil Kumar, Managing Director - Sales · Updated 14 Oct 2026

A lab technician loads sample trays of amber bottles and blister packs into a glass-doored pharmaceutical stability chamber.

Key takeaways

  • Use the most severe long-term condition among your destination markets. 30°C/75% RH is the most severe condition listed for all but one of the 193 WHO member states; Comoros lists 30°C/80% RH. For packs that lose water (semi-permeable containers), also check low-humidity markets, because 30/35 gives about 2.6 times the water loss of 30/75.
  • Zone I is not tested at 21°C/45% RH. The long-term condition for zones I and II is 25°C/60% RH, with 30°C/65% RH as an allowed alternative.
  • The condition you test at fixes the storage statement you can print. Data at 25°C/60% RH supports "Do not store above 25 °C", not a 30 °C statement.
  • Check a supplier's stability package against five tests: condition, duration and batches, accelerated results, storage statement and container-closure system.
In this article
  1. 1What long-term conditions do the ICH stability zones set?
  2. 2Which stability zone condition does each market require?
  3. 3Why do common zone tables mislead?
  4. 4What does 25°C/60% RH data let you put on the label in a hot, humid market?
  5. 5How do you test a supplier's stability package?
  6. 6What can you ask us for on a zone-specific API request?
  7. 7Frequently asked questions

A zone table tells you what a climate is like. It does not tell you what a regulator will accept, and the two differ more than most tables admit. In WHO's March 2021 table of member-state stability conditions, 115 of 193 states list 30°C/65% RH as a long-term condition and 36 list 30°C/75% RH (our tally, as of October 2026).

That spread matters in practice. A product tested only for a temperate market may not support the storage statement a humid market expects, and a supplier's stability report written for one zone may be of no use for your destination.

This page sets out the conditions for each zone, where common zone tables go wrong, how to choose one condition for several markets, and five tests for a supplier's stability package. Climatic zones are the climate bands used in stability testing: I temperate, II subtropical or Mediterranean, III hot and dry, IVa hot and humid, IVb hot and very humid. ICH is the International Council for Harmonisation, WHO is the World Health Organization and RH is relative humidity.

What long-term conditions do the ICH stability zones set?

The ICH stability zones set the long-term test condition for each climate (up to three options in some zones), with 40°C/75% RH as the accelerated condition for products stored at room temperature. The table below follows Table 3 of the 2025 ICH Q1 draft, which was released for comment on 11 April 2025.

ZoneLong-termIntermediateAccelerated (room-temperature products)
I and II25°C/60% RH, or 30°C/65% RH, or 30°C/75% RH30°C/65% RH or 30°C/75% RH, only when long-term is 25/60 and accelerated shows significant change (for an API, failure to meet its specification)40°C/75% RH
III (hot, dry)30°C/35% RH, or 30/65, or 30/75None40°C/75% RH
IVa30°C/65% RH or 30°C/75% RHNone40°C/75% RH
IVb30°C/75% RHNone40°C/75% RH

Long-term studies run at least 12 months before submission. The guideline currently in force, ICH Q1A(R2), covers zones I and II only: 25°C/60% RH or 30°C/65% RH long-term, 30°C/65% RH intermediate, 40°C/75% RH accelerated. WHO Technical Report Series No. 1010, Annex 10 covers all climatic zones, including III and IV, and lists 25°C/60% RH, 30°C/65% RH and 30°C/75% RH as long-term options.

As of 14 October 2026 the consolidated ICH Q1 is still a Step 2 draft; ICH's work plan anticipates final adoption (Step 4) in November 2026. Until then, ICH Q1A(R2) and WHO Annex 10 apply.

Which stability zone condition does each market require?

Most markets list 30°C/65% RH (115 of 193 states), and 30°C/75% RH is listed by 36. This is our tally of the 193 member-state rows in WHO's March 2021 stability-conditions table, counted as of October 2026.

Two pharmaceutical professionals study a tinted world map, pointing at one region while discussing market requirements.
Each market sits in its own climate band, so the condition you test at depends on where the product will be sold.
Condition listedStatesShare of 193
30°C/65% RH only7840%
25°C/60% RH only3719%
25°C/60% RH or 30°C/65% RH3719%
30°C/75% RH only3116%
30°C/70% RH or 30°C/75% RH53%
Other (30/35, 30/50, 30/60, 30/70, 30/80; one state each)53%

Counting any state that lists the condition, 30/65 appears for 115 states (60%), 25/60 for 74 (38%) and 30/75 for 36 (19%). WHO's table marks 92 of the 193 entries (48%) in square brackets as supplied by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) rather than by regulators. Confirm bracketed entries with the destination regulator.

For markets we commonly discuss with buyers:

MarketLong-term conditionEntry type
USA, Canada, Germany25°C/60% RH or 30°C/65% RHRegulator or regional group, per WHO's table
Mexico25°C/60% RH or 30°C/65% RH, per NOM-073-SSA1-2015 (Mexico's official stability standard)Regulator
Brazil, Peru30°C/75% RHRegulator or regional group, per WHO's table
India30°C/70% RHRegulator or regional group, per WHO's table
Colombia30°C/75% RHIFPMA, unconfirmed
Bolivia30°C/70% RH or 30°C/75% RHIFPMA, unconfirmed

Take the market with the highest humidity and use its condition. A study for the USA, Brazil and Peru runs at 30°C/75% RH. A study for the USA and Mexico can run at 25°C/60% RH or 30°C/65% RH. Our recommendation is to treat 30°C/75% RH data as covering India's 30°C/70% RH too, because it is the more severe condition. The ICH Q1 draft supports the principle: data generated under a more severe zone condition is acceptable in the others, provided labelling follows regional requirements. Some regions set stricter requirements, so check each regulator.

If a product fails at 30°C/75% RH, the draft lists the options: an alternative long-term condition for the intended zone, a modest cut to the retest period or shelf life, a different container-closure system, or reformulation. Retest period is the interval an API is expected to stay within specification; shelf life is the equivalent for a finished product.

Why do common zone tables mislead?

Common zone tables mislead in three places: the Zone I condition, the status of ICH Q1F, and the idea that a country has one tidy zone.

Zone I is not tested at 21°C/45% RH. ICH Q1A(R2) addresses zones I and II together and names 25°C/60% RH or 30°C/65% RH as the long-term condition. None of the 193 entries in WHO's table lists 21/45. Using it in a protocol would put your data below the condition any regulator in the table asks for.

ICH withdrew Q1F. Q1F had set 30°C/65% RH for zones III and IV. Some countries wanted a larger safety margin, so ICH withdrew Q1F and left zone III and IV conditions to regions and WHO. ICH therefore does not decide the IVb condition for a given country; the national regulator does.

A country does not have one tidy zone. India is listed by WHO at 30°C/70% RH, which sits between the IVa and IVb conditions. Brazil and Peru list 30°C/75% RH. Use the country's own listed condition, not a zone label.

What does 25°C/60% RH data let you put on the label in a hot, humid market?

Data at 25°C/60% RH supports "Do not store above 25 °C" and nothing warmer. WHO Annex 10, Appendix 3 says a product approved in zone II on zone II data should carry "Do not store above 25 °C. Protect from moisture" when distributed in zone IV. A 30 °C statement needs 30/65 or 30/75 data.

The statements below come from WHO Annex 10, Appendix 2, Tables A10.1 (APIs) and A10.2 (finished products), which are identical in this respect:

Data behind the productWHO-recommended statement
25/60 long-term, 40/75 accelerated"Do not store above 25 °C"
30/65 long-term, 40/75 accelerated"Do not store above 30 °C", plus "Protect from moisture" where applicable
30/75 long-term, 40/75 accelerated"Do not store above 30 °C"
5 °C ± 3 °C"Store in a refrigerator (2 °C to 8 °C)"

WHO adds that a storage statement should not be used to compensate for inadequate or inferior packaging. It also notes that 30/65 may be acceptable in place of 30/75 where humidity is not an issue, for example storage in glass containers.

Worked example, using WHO's water-loss method for semi-permeable packs. The ratio between humidity conditions at the same temperature is (100 − low RH) ÷ (100 − alternative RH). For 30/35 against 30/75, that is 65 ÷ 25 = 2.6. If a hypothetical oral solution bottle loses 0.4% of its weight per month at 30°C/75% RH, the expected loss at 30°C/35% RH is 0.4 × 2.6 = 1.04% per month. WHO's own table gives 1.9 for 30/35 against 30/65 and 3.0 for 40/NMT 25 against 40/75. The loss figure is our illustration, not a measured value.

How do you test a supplier's stability package?

Test a supplier's stability package with five checks, each of which has a pass or a fail result. Run them on the report before you rely on a retest period for your market. A COA (certificate of analysis) is the batch-specific certificate a supplier issues; see how to read a steroid API COA for that document.

A quality reviewer examines a printed stability report next to a sample bottle and a blank checklist card.
Checking a supplier's report page by page, against the physical sample, turns each stability claim into a pass or a fail.
  1. 1
    Condition
    The long-term condition on the report equals or exceeds your market's condition from the table above. Pass: a report at 30°C/75% RH for a Peru-bound product. Fail: 25°C/60% RH only.
  2. 2
    Duration and batches

    For an API, ICH Q1A(R2) expects at least 12 months of long-term data on at least three primary batches (the batches the registration stability study is run on) at submission. Pass: the report shows both. Fail: one batch or under 12 months.

  3. 3
    Accelerated result

    For a room-temperature API, the report shows six months at 40°C/75% RH, and a significant change (failure to meet specification) is followed by intermediate data when long-term is 25/60. Pass: no failure, or intermediate data supplied. Fail: a failure with no follow-up. For a refrigerated API, the accelerated condition is 25°C/60% RH for six months; if significant change occurs within the first three months, Q1A(R2) calls for a discussion of short-term excursions such as shipping, which is why our guide to a peptide API temperature excursion matters for cold-chain material. Pass: the discussion is in the file. Fail: it is missing.

  4. 4
    Storage statement
    The statement on the COA or label matches the table above. Pass: "Do not store above 30 °C" backed by 30/65 or 30/75 data. Fail: an unspecific "store at ambient temperature" or a statement warmer than the data.
  5. 5
    Container-closure system
    The report names the pack the product ships in, and the label does not lean on "Protect from moisture" to rescue a weak pack. Pass: study pack and shipping pack match. Fail: they differ.

The stability program that sits behind a retest date is also an expectation of good manufacturing practice, covered in ICH Q7 explained.

What can you ask us for on a zone-specific API request?

When you request an API quote from us, tell us the destination market and the long-term condition you need, and ask whether stability data for that condition exist for the specific product. We supply steroid, peptide, hormone and general pharmaceutical APIs as bulk raw material to business buyers, and documentation is confirmed product by product.

Our quote request asks for the product name or CAS number (the Chemical Abstracts Service registry number), quantity, destination, grade or purity, documents, payment terms and Incoterms (the international shipping terms). Available documentation may include the COA, specifications and SDS/MSDS (safety data sheet) where applicable. We support evaluation quantities for qualified business buyers, so you can test a batch against your own protocol before committing to bulk. We discuss requirements in English, and in Spanish for Latin American customers. Prices are quoted per product on request.

For more on how we test materials, see our pharmaceutical API quality testing guide. To start a request, contact us with your product, destination and the stability condition you need.

Talk to our team

Leave your details and we'll get back to you.

Frequently asked questions

Yes, if every destination regulator lists 30°C/65% RH, for example the USA, Canada and Germany. For Brazil and Peru, which list 30°C/75% RH, you cannot.
No. Accelerated data at 40°C/75% RH is the same in every zone in the ICH Q1 draft for room-temperature products; each zone still has its own long-term condition. Accelerated results support the evaluation, but they do not replace long-term data at 30°C/65% RH or 30°C/75% RH.
Zone IVa is 30°C/65% RH and zone IVb is 30°C/75% RH, so they differ only in humidity. In the ICH Q1 draft, IVa may use either condition, while IVb allows only 30°C/75% RH.
APIs need it too. WHO Annex 10 sets long-term conditions for APIs as well as finished products, and the retest period depends on the climatic zone the API is intended for. Its labelling table for APIs matches the one for finished products.
No. ICH's work plan anticipates final adoption (Step 4) of the consolidated Q1 in November 2026.

Sources

  1. 1.ICH Q1A(R2): Stability Testing of New Drug Substances and Products
  2. 2.ICH Q1 consolidated draft guideline, Step 2, 11 April 2025
  3. 3.ICH Q1 Expert Working Group work plan, 2026
  4. 4.WHO Technical Report Series No. 1010, Annex 10 (2018): Stability testing of active pharmaceutical ingredients and finished pharmaceutical products, including the ICH Q1F withdrawal note
  5. 5.WHO: Stability conditions for WHO Member States by Region, update March 2021

Keep reading

Aarise Pharma.

© 2026 Aarise Pharma

Powered by PageLens.ai

Get in touch — we'd love to help.

Contact us